Effective Therapy Targeting Cytochrome bc1 Prevents Babesia Erythrocytic Development and Protects from Lethal Infection

JE Chiu, I Renard, AC Pal, P Singh… - Antimicrobial agents …, 2021 - Am Soc Microbiol
An effective strategy to control blood-borne diseases and prevent outbreak recrudescence
involves targeting conserved metabolic processes that are essential for pathogen viability. …

Babesia duncani as a Model Organism to Study the Development, Virulence, and Drug Susceptibility of Intraerythrocytic Parasites In Vitro and In Vivo

AC Pal, I Renard, P Singh, P Vydyam… - The Journal of …, 2022 - academic.oup.com
Human babesiosis is a malaria-like illness caused by tick-borne intraerythrocytic Babesia
parasites of the Apicomplexa phylum. Whereas several species of Babesia can cause severe …

Tafenoquine-atovaquone combination achieves radical cure and confers sterile immunity in experimental models of human Babesiosis

P Vydyam, AC Pal, I Renard, M Chand… - The Journal of …, 2024 - academic.oup.com
Human babesiosis is a potentially fatal tick-borne disease caused by intraerythrocytic Babesia
parasites. The emergence of resistance to recommended therapies highlights the need …

An Alternative Culture Medium for Continuous In Vitro Propagation of the Human Pathogen Babesia duncani in Human Erythrocytes

P Singh, AC Pal, CB Mamoun - Pathogens, 2022 - mdpi.com
Continuous propagation of Babesia duncani in vitro in human erythrocytes and the availability
of a mouse model of B. duncani lethal infection make this parasite an ideal model to study …

Specific and sensitive diagnosis of Babesia microti active infection using monoclonal antibodies to the immunodominant antigen BmGPI12

…, P Singh, P Lamba, G Gaur, AC Pal… - Journal of Clinical …, 2022 - Am Soc Microbiol
The apicomplexan pathogen Babesia microti is responsible for most cases of human babesiosis
worldwide. The disease, which presents as a malaria-like illness, is potentially fatal in …

Cytochrome b Drug Resistance Mutation Decreases Babesia Fitness in the Tick Stages But Not the Mammalian Erythrocytic Cycle

JE Chiu, I Renard, S George, AC Pal… - The Journal of …, 2022 - academic.oup.com
Human babesiosis is an emerging tick-borne malaria-like illness caused by Babesia parasites
following their development in erythrocytes. Here, we show that a mutation in the Babesia …

Evidence for SARS-CoV-2 spike protein in the urine of COVID-19 patients

S George, AC Pal, J Gagnon, S Timalsina, P Singh… - Kidney360, 2021 - journals.lww.com
… Urine protein analyses further revealed proteinuria with elevated albumin and cystatin C in
… Urinary levels of SARS-CoV-2 spike protein, albumin, and cystatin C were normalized to …

Epitope profiling of monoclonal antibodies to the immunodominant antigen BmGPI12 of the human pathogen Babesia microti

M Chand, JY Choi, AC Pal, P Singh… - Frontiers in Cellular …, 2022 - frontiersin.org
The significant rise in the number of tick-borne diseases represents a major threat to public
health worldwide. One such emerging disease is human babesiosis, which is caused by …

Evidence for a Conserved Function of Eukaryotic Pantothenate Kinases in the Regulation of Mitochondrial Homeostasis and Oxidative Stress

…, JY Choi, AC Pal, P Goffrini, C Ben Mamoun - International Journal of …, 2022 - mdpi.com
Human PANK1, PANK2, and PANK3 genes encode several pantothenate kinase isoforms
that catalyze the phosphorylation of vitamin B5 (pantothenic acid) to phosphopantothenate, a …

[PDF][PDF] High-resolution crystal structure and chemical screening reveal pantothenate kinase as a new target for antifungal development

S Gihaz, P Gareiss, JY Choi, I Renard, AC Pal… - Structure, 2022 - cell.com
Fungal infections are the leading cause of mortality by eukaryotic pathogens, with an estimated
150 million severe life-threatening cases and 1.7 million deaths reported annually. The …